Research & Development



  「事的。如果有雷克斯的消息的,我第一跟你的。」王瑟安慰道。   就那看了一,那人最後是放了捏住汪大下巴的手,且他修被自己打的。修完後,站起,矗立在在月光下的的花里,仰看著月亮,月光映在他的上,白的皮,冰色的眸子,金色的,整人透著一股冰冷的息,夜的水落在他的皮上都成小的冰晶,在月下光。哥哥去 哥哥撸   「George,奈特他不會再犯下那樣的罪了!你知道的,每個剛變成吸血鬼的人都要經歷那樣一番折磨,是我那時候沒有在他身邊照顧他,否則他也不會去攻擊那些村民!這些日子以來,他有逐漸在適應和克制吸血的欲望,他不會再那樣了,拜托你!」Roy請求George。 哥哥操   「奈特……你為什會變成這個樣子?」Roy問道,「你不是很後悔殺人嗎?為什又要傷害那多人?」

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo